Table 2.
Parameter | This study | Manufacturer provided | N/N | N/A | A/N | A/A |
---|---|---|---|---|---|---|
R | 2.80‐7.17** | 5.00‐10.00 | 162 | 195 | 4 | 10 |
Angle | 44.73‐78.88** | 53.00‐72.00 | 199 | 155 | 0 | 17 |
K | 0.80‐4.57** | 1.00‐3.00 | 277 | 87 | 0 | 7 |
MA | 43.92‐74.65** | 50.00‐70.00 | 262 | 91 | 0 | 18 |
LY30 | 0.10‐6.94 | 0.00‐8.00 | 363 | 0 | 2 | 6 |
The McNemar test was used for the analysis between the reference ranges determined in our study and provided by manufacturers. R (s), K (s), Angle (α), maximum amplitude (MA, mm) and lysis at 30 min (LY30, %).
Abbreviation(s): A/A, abnormal data evaluated by both methods; A/N, abnormal data evaluated by this study, normal data evaluated by manufacturers; N/A, normal data evaluated by this study, abnormal data evaluated by manufacturers; N/N, normal data evaluated by both methods; TEG, thromboelastograph.
P < 0.01.